TrueCopy Mutation Controls

About TrimGen

TrimGen is a U.S.-based developer and provider of molecular diagnostic products focused on genetic mutation analysis. The company's proprietary Shifted Termination Assay (STA) technology enables rapid, sensitive, and cost-effective detection of key mutations in hematopoietic cancers and for pharmacogenetic applications. Its product portfolio targets clinical research and early disease detection, offering an alternative to more expensive and time-consuming methods like NGS and Sanger sequencing. As a private company, TrimGen serves a global customer base of biomedical laboratories.

Therapeutic Areas